Suppr超能文献

脂肪组织来源的低操作产品与富血小板血浆治疗膝关节骨关节炎的比较:临床证据的系统评价和荟萃分析

Adipose Tissue-Derived Minimally Manipulated Products versus Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis: A Systematic Review of Clinical Evidence and Meta-Analysis.

作者信息

Veronesi Francesca, Andriolo Luca, Salerno Manuela, Boffa Angelo, Giavaresi Gianluca, Filardo Giuseppe

机构信息

Surgical Sciences and Technologies, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Clinica Ortopedica e Traumatologica 2, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

出版信息

J Clin Med. 2023 Dec 22;13(1):67. doi: 10.3390/jcm13010067.

Abstract

The use of minimally manipulated adipose tissue (MM-AT) products is gaining increasing interest for the treatment of knee osteoarthritis (OA). MM-AT represents an easy way to exploit adipose tissue properties, although clinical evidence is still limited, as well as their benefits with respect to more documented orthobiologics like platelet-rich plasma (PRP). A systematic review and meta-analysis were performed to evaluate the safety and efficacy of MM-AT products for knee OA management. The risk of bias of the included studies was evaluated using the Dawns and Black checklist for all the included studies and RoB-2.0 for randomized controlled trials (RCTs). Thirty-three clinical studies were included in the qualitative analysis: 13 prospective case series, 10 retrospective case series, 7 RCTs, 2 retrospective comparative studies, and 1 prospective comparative study. An overall clinical improvement and few minor adverse events were observed. Five RCTs comparing MM-AT and PRP injections were meta-analyzed, showing comparable results. The analysis also highlighted the limits of the literature, with only a few high-level trials and an overall low quality. Even though the current literature is still limited, the available evidence suggests the safety and overall positive results of the intra-articular injections of MM-AT products for knee OA treatment.

摘要

使用微处理脂肪组织(MM-AT)产品治疗膝关节骨关节炎(OA)越来越受到关注。MM-AT是一种利用脂肪组织特性的简便方法,尽管临床证据仍然有限,而且与记录更详尽的诸如富血小板血浆(PRP)等骨科生物制剂相比,其益处也不明确。进行了一项系统综述和荟萃分析,以评估MM-AT产品治疗膝关节OA的安全性和有效性。使用Dawns和Black清单对所有纳入研究进行偏倚风险评估,对随机对照试验(RCT)使用RoB-2.0进行评估。定性分析纳入了33项临床研究:13项前瞻性病例系列、10项回顾性病例系列、7项RCT、2项回顾性比较研究和1项前瞻性比较研究。观察到总体临床改善且不良事件较少。对5项比较MM-AT和PRP注射的RCT进行了荟萃分析,结果显示二者相当。分析还突出了文献的局限性,只有少数高水平试验且总体质量较低。尽管目前的文献仍然有限,但现有证据表明关节内注射MM-AT产品治疗膝关节OA具有安全性和总体积极效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8405/10780289/607ca31e07db/jcm-13-00067-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验